The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Hypercalcemia of Malignancy

Mechanisms, presentation and rapid treatment in cancer patients

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Hypercalcemia of Malignancy?

Hypercalcemia of malignancy occurs in up to 30 percent of patients with advanced cancer.

Mechanisms include PTHrP secretion (squamous cell, breast, renal), local osteolysis (multiple myeloma, breast), ectopic 1,25-dihydroxyvitamin D (lymphomas, granulomatous disease) and rare ectopic parathyroid hormone.

Severity ranges from mild (corrected calcium 10.5 to 12 mg/dL) to severe (above 14 mg/dL) and life-threatening (above 16 mg/dL).

Diagnostic workup includes ionized or corrected calcium, PTH, PTHrP, 25 and 1,25 vitamin D, phosphate, creatinine and urinary calcium.

Hypercalcemic crisis is a medical emergency with significant mortality if untreated.

Symptoms

Polyuria, polydipsia and dehydration from impaired urine concentration.
Anorexia, nausea, vomiting, constipation and abdominal pain.
Fatigue, weakness, depression, confusion, delirium, lethargy or coma.
Cardiac symptoms include shortened QT interval, arrhythmias and bradycardia.
Renal stones, nephrocalcinosis and worsening kidney function in chronic cases.

Risk Factors

Advanced cancer with bony metastases, breast cancer, multiple myeloma, lung cancer, renal cell carcinoma and squamous cell tumors.
Hematologic malignancies including non-Hodgkin lymphoma and adult T-cell leukemia/lymphoma.
Long bone immobilization and dehydration potentiate hypercalcemia.
Concurrent use of thiazide diuretics, lithium, vitamin D or calcium supplements.
Pre-existing kidney impairment, hyperparathyroidism or vitamin D excess complicate management.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Severe symptoms (confusion, dehydration, vomiting) or calcium above 14 mg/dL need emergency hospitalization.
  • Worsening kidney function, low urine output or arrhythmias require urgent assessment.
  • Persistent constipation, polyuria or unexplained mental changes in cancer patients should prompt calcium evaluation.
  • Suspected pathologic fractures, severe bone pain or progressive weakness need imaging and oncology review.
  • Routine follow-up monitors calcium during cancer therapy and supportive care.

Treatment Methods

01
Aggressive intravenous saline hydration with 200 to 500 mL/hour titrated to maintain urine output 100 to 150 mL/hour.
02
Subcutaneous calcitonin 4 IU/kg every 12 hours for 24 to 48 hours provides rapid but tachyphylaxis-limited reduction.
03
Intravenous bisphosphonates (zoledronic acid 4 mg, pamidronate 60 to 90 mg) reduce calcium over 2 to 4 days with effects lasting weeks.
04
Denosumab is preferred when bisphosphonates are contraindicated, refractory hypercalcemia or kidney impairment.
05
Treatment of underlying malignancy with chemotherapy, immunotherapy or targeted therapy is essential; glucocorticoids are effective for vitamin D-mediated hypercalcemia (lymphoma, granulomatous disease); dialysis is used in severe refractory cases.

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.